BIOMAT Database Logo BIOMAT Database Logo

[Clinical study of a new anxiolytic agent (oxazepam)]. 1965

G Audéoud

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010076 Oxazepam A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia. Adumbran,Serax,Tazepam
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders

Related Publications

G Audéoud
[DIAZEPAM: A NEW ANXIOLYTIC AGENT].
April 1964, La Presse medicale,
G Audéoud
[A clinical study of a new benzodiazepine anxiolytic agent, ethyl loflazepate, in dental practice].
December 1982, Revue d'odonto-stomatologie,
G Audéoud
[Clinical experiences with the new-generation anxiolytic agent cloxazolam--a double-blind study].
July 1985, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
G Audéoud
Topics in clinical pharmacology: buspirone: a new nonbenzodiazepine anxiolytic agent.
January 1989, The American journal of the medical sciences,
G Audéoud
[Preliminary note on a new antianxiety agent: oxazepam].
November 1966, Minerva medica,
G Audéoud
[Clinical study of the selective anxiolytic agent afobazol].
January 2001, Eksperimental'naia i klinicheskaia farmakologiia,
G Audéoud
[Clinical therapeutic experience with a new tranquilizing agent of the benzodiazepin series (oxazepam)].
January 1968, Wiener Zeitschrift fur Nervenheilkunde und deren Grenzgebiete,
G Audéoud
Pharmacology of oxazepam (Serax), a new anti-anxiety agent.
November 1965, Current therapeutic research, clinical and experimental,
G Audéoud
Effects of the anxiolytic benzodiazepine oxazepam on freshwater gastropod reproduction: a prospective study.
November 2021, Ecotoxicology (London, England),
G Audéoud
[Clinical study of a new anxiolytic agent: CB 4306 in current medical practice. (Apropos of 93 cases)].
January 1968, Lyon medical,
Copied contents to your clipboard!